163 related articles for article (PubMed ID: 32172165)
1. Biodegradation model of porous silicon nanoparticles.
Gongalsky MB; Sviridov AP; Bezsudnova YI; Osminkina LA
Colloids Surf B Biointerfaces; 2020 Jun; 190():110946. PubMed ID: 32172165
[TBL] [Abstract][Full Text] [Related]
2. Active diffusion of nanoparticles of maternal origin within the embryonic brain.
Yuryev M; Ferreira MP; Balasubramanian V; Correia AM; Mäkilä EM; Jokinen V; Andriichuk L; Kemell M; Salonen JJ; Hirvonen JT; Santos HA; Rivera C
Nanomedicine (Lond); 2016 Oct; 11(19):2471-81. PubMed ID: 27622305
[TBL] [Abstract][Full Text] [Related]
3. Temperature responsive porous silicon nanoparticles for cancer therapy - spatiotemporal triggering through infrared and radiofrequency electromagnetic heating.
Tamarov K; Xu W; Osminkina L; Zinovyev S; Soininen P; Kudryavtsev A; Gongalsky M; Gaydarova A; Närvänen A; Timoshenko V; Lehto VP
J Control Release; 2016 Nov; 241():220-228. PubMed ID: 27686581
[TBL] [Abstract][Full Text] [Related]
4. Dual-drug delivery by porous silicon nanoparticles for improved cellular uptake, sustained release, and combination therapy.
Wang CF; Mäkilä EM; Kaasalainen MH; Hagström MV; Salonen JJ; Hirvonen JT; Santos HA
Acta Biomater; 2015 Apr; 16():206-14. PubMed ID: 25637067
[TBL] [Abstract][Full Text] [Related]
5. Size tuning of luminescent silicon nanoparticles with meso-porous silicon membranes.
Serdiuk T; Lysenko V; Alekseev S; Skryshevsky VA
J Colloid Interface Sci; 2011 Dec; 364(1):65-70. PubMed ID: 21890146
[TBL] [Abstract][Full Text] [Related]
6. Preparation and in vivo evaluation of red blood cell membrane coated porous silicon nanoparticles implanted with
Jakobsson U; Mäkilä E; Rahikkala A; Imlimthan S; Lampuoti J; Ranjan S; Heino J; Jalkanen P; Köster U; Mizohata K; Santos HA; Salonen J; Airaksinen AJ; Sarparanta M; Helariutta K
Nucl Med Biol; 2020; 84-85():102-110. PubMed ID: 32334356
[TBL] [Abstract][Full Text] [Related]
7. Ultrathin Silicon Membranes for
Hudecz D; Khire T; Chung HL; Adumeau L; Glavin D; Luke E; Nielsen MS; Dawson KA; McGrath JL; Yan Y
ACS Nano; 2020 Jan; 14(1):1111-1122. PubMed ID: 31914314
[TBL] [Abstract][Full Text] [Related]
8. Surface chemistry dependent immunostimulative potential of porous silicon nanoplatforms.
Shahbazi MA; Fernández TD; Mäkilä EM; Le Guével X; Mayorga C; Kaasalainen MH; Salonen JJ; Hirvonen JT; Santos HA
Biomaterials; 2014 Nov; 35(33):9224-35. PubMed ID: 25123922
[TBL] [Abstract][Full Text] [Related]
9. Metallothermic Reduction of Silica Nanoparticles to Porous Silicon for Drug Delivery Using New and Existing Reductants.
Lai Y; Thompson JR; Dasog M
Chemistry; 2018 Jun; 24(31):7913-7920. PubMed ID: 29569356
[TBL] [Abstract][Full Text] [Related]
10. Porous silicon nanoparticles for nanomedicine: preparation and biomedical applications.
Santos HA; Mäkilä E; Airaksinen AJ; Bimbo LM; Hirvonen J
Nanomedicine (Lond); 2014 Apr; 9(4):535-54. PubMed ID: 24787441
[TBL] [Abstract][Full Text] [Related]
11. Multifunctional porous silicon nanoparticles for cancer theranostics.
Wang CF; Sarparanta MP; Mäkilä EM; Hyvönen ML; Laakkonen PM; Salonen JJ; Hirvonen JT; Airaksinen AJ; Santos HA
Biomaterials; 2015 Apr; 48():108-18. PubMed ID: 25701036
[TBL] [Abstract][Full Text] [Related]
12. Long duration stabilization of porous silicon membranes in physiological media: Application for implantable reactors.
Baraket A; Alcaraz JP; Gondran C; Costa G; Nonglaton G; Gaillard F; Cinquin P; Cosnier ML; Martin DK
Mater Sci Eng C Mater Biol Appl; 2020 Mar; 108():110359. PubMed ID: 31923938
[TBL] [Abstract][Full Text] [Related]
13. Size Control of Porous Silicon-Based Nanoparticles via Pore-Wall Thinning.
Secret E; Leonard C; Kelly SJ; Uhl A; Cozzan C; Andrew JS
Langmuir; 2016 Feb; 32(4):1166-70. PubMed ID: 26796986
[TBL] [Abstract][Full Text] [Related]
14. Biodegradation of inorganic drug delivery systems in subcutaneous conditions.
Kovalainen M; Kamakura R; Riikonen J; Finnilä M; Nissinen T; Rantanen J; Niemelä M; Perämäki P; Mäkinen M; Herzig KH; Lehto VP
Eur J Pharm Biopharm; 2018 Jan; 122():113-125. PubMed ID: 29056485
[TBL] [Abstract][Full Text] [Related]
15. Silver Coating for High-Mass-Accuracy Imaging Mass Spectrometry of Fingerprints on Nanostructured Silicon.
Guinan TM; Gustafsson OJ; McPhee G; Kobus H; Voelcker NH
Anal Chem; 2015 Nov; 87(22):11195-202. PubMed ID: 26460234
[TBL] [Abstract][Full Text] [Related]
16. Tailoring the biodegradability of porous silicon nanoparticles.
Hon NK; Shaposhnik Z; Diebold ED; Tamanoi F; Jalali B
J Biomed Mater Res A; 2012 Dec; 100(12):3416-21. PubMed ID: 22767395
[TBL] [Abstract][Full Text] [Related]
17. Recent Developments in Porous Silicon Nanovectors with Various Imaging Modalities in the Framework of Theranostics.
Qian J; Wen H; Tamarov K; Xu W; Lehto VP
ChemMedChem; 2022 May; 17(10):e202200004. PubMed ID: 35212460
[TBL] [Abstract][Full Text] [Related]
18. ISD3: a particokinetic model for predicting the combined effects of particle sedimentation, diffusion and dissolution on cellular dosimetry for in vitro systems.
Thomas DG; Smith JN; Thrall BD; Baer DR; Jolley H; Munusamy P; Kodali V; Demokritou P; Cohen J; Teeguarden JG
Part Fibre Toxicol; 2018 Jan; 15(1):6. PubMed ID: 29368623
[TBL] [Abstract][Full Text] [Related]
19. Surface chemistry of porous silicon and implications for drug encapsulation and delivery applications.
Jarvis KL; Barnes TJ; Prestidge CA
Adv Colloid Interface Sci; 2012 Jul; 175():25-38. PubMed ID: 22521238
[TBL] [Abstract][Full Text] [Related]
20. Protease-targeting peptide-functionalized porous silicon nanoparticles for cancer fluorescence imaging.
Kanathasan JS; Palanisamy UD; Radhakrishnan AK; Chakravarthi S; Thong TB; Swamy V
Nanomedicine (Lond); 2022 Sep; 17(21):1511-1528. PubMed ID: 36382634
[No Abstract] [Full Text] [Related]
[Next] [New Search]
